Using Microbial Detection Array for Virus Detection in Clinical Samples
Author Information
Author(s): Erlandsson Lena, Rosenstierne Maiken W., McLoughlin Kevin, Jaing Crystal, Fomsgaard Anders
Primary Institution: Statens Serum Institut, Copenhagen, Denmark
Hypothesis
Can a diagnostic microarray combined with random amplification effectively identify viral pathogens in clinical samples?
Conclusion
The study demonstrates that the microarray technique can successfully detect both DNA and RNA viruses in clinical samples.
Supporting Evidence
- The method successfully identified expected viruses in all clinical samples tested.
- Phi29-amplification generated sufficient viral material for detection.
- The microarray can detect both DNA and RNA viruses from the same sample.
- Multiple virus subtypes were identified without cross-hybridization.
- Detection of viruses not previously tested in routine analysis was achieved.
Takeaway
Researchers created a new test that can find many different viruses in one go, making it easier to diagnose infections.
Methodology
The study used a combination of pre-treatment, nucleic acid purification, Phi29-amplification, and microarray analysis to detect viruses in clinical samples.
Potential Biases
Potential cross-reactivity between probes could lead to false positives.
Limitations
The protocol is currently too time and labor-intensive for routine use.
Participant Demographics
Clinical samples were collected from various sources including skin lesions, urine, cerebrospinal fluid, cervical smears, serum, feces, and tracheal aspirates.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website